- Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
-
Takekuma M, Kuji S, Tanaka A, Takahashi , Abe M, Hirashima
- KMID: 2160804
- J Gynecol Oncol.
- 2015 Jul;26(3):185-192.
- doi: 10.3802/jgo.2015.26.3.185
OBJECTIVE: The concept of platinum sensitivity and cross-resistance among platinum agents are widely known in the management of recurrent ovarian cancer. The aim of this study was to evaluate two... -
- CITED
-
- Close
- SHARE
-
- Close
- High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer
-
Sakaguchi , Motohara T, Saito F, Takaishi K, Fukumatsu , Tohya T, Shibata S, Mimori H, Tashiro H, Katabuchi
- KMID: 2160805
- J Gynecol Oncol.
- 2015 Jul;26(3):193-200.
- doi: 10.3802/jgo.2015.26.3.193
OBJECTIVE: The aim of this study was to determine the efficacy and toxicity of oral administration of tegafur-uracil (UFT) at a high dose, 600 mg/day, based on the tegafur dose,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
-
Scandurra , Scibilia G, Banna GL, D'Agate G, Lipari H, Gieri S, Scollo P
- KMID: 2160794
- J Gynecol Oncol.
- 2015 Apr;26(2):118-124.
- doi: 10.3802/jgo.2015.26.2.118
OBJECTIVE: To evaluate the efficacy and tolerability of a neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy in patients with locally advanced cervical carcinoma. METHODS: Patients with histologically confirmed locally advanced cervical carcinoma,... -
- CITED
-
- Close
- SHARE
-
- Close
